XBiotech: XBiotech Inc. Reports Earnings Results for the Full Year Ended December 31, 2024

XBiotech Inc. reported earnings results for the full year ended December 31, 2024. For the full year, the company reported net loss was USD 38.53 million compared to USD 24.56 million a year ago. Basic loss per share from continuing operations was USD 1.26 compared to USD 0.81 a year ago. Diluted loss per share from continuing operations was USD 1.26 compared to USD 0.81 a year ago. XBiotech Inc. reported earnings results for the full year ended December 31, 2024. For the full year, the company reported net loss was USD 38.53 million compared to USD 24.56 million a year ago. Basic loss per share from continuing operations was USD 1.26 compared to USD 0.81 a year ago. Diluted loss per share from continuing operations was USD 1.26 compared to USD 0.81 a year ago.